Background: Basal cell adenocarcinoma is an uncommon basaloid malignancy seen most frequently in the salivary glands. Due to the rarity of this tumor data on survival and treatment is limited. Aim: The aim of this study was to examine factors affecting survival in patients with basal cell adenocarcinoma. Methods: The 1973-2014 Surveillance, Epidemiology, and End Results database was queried for patients with basal cell adenocarcinoma. The data was analyzed for tumor staging, site, and demographic characteristics. The Kaplan-Meier model was used to estimate actuarial survival. Results: A total of 247 patients were identified with complete TNM staging data. White patients represented 83.0% of the total (205/247). Patients were 51.0% female (126/247) and 49.0% male (121/247). Overall 5- and 10-year survival was 80.6% and 65.0%, respectively. Mean survival time was 100.8 months. Parotid gland was the most common site, followed by skin, submandibular gland, mouth/oral cavity, and vulva. Most patients were stage T1 or T2. Distant metastasis was present in only 1.6% (4/247) patients. 93.1% (230/247) of patients had surgical treatment. On univariate analysis T stage, primary tumor site, presence of distant metastasis, age, sex, and AJCC stage significantly affected survival. On multivariate analysis age and T stage remained significant. Conclusions: Basal cell adenocarcinoma is a basaloid malignancy most frequently seen in the parotid gland. The survival rate is high, and nodal and distant metastasis rates are low. Surgery is the mainstay of treatment, and T and M stage, primary site, age, sex, and AJCC stage all significantly affected survival.
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 24805 citations as per google scholar report
The Annals of Medical and Health Sciences Research is a bi-monthly multidisciplinary medical journal.